Advertisement

Reactions Weekly

, Volume 1738, Issue 1, pp 102–102 | Cite as

Dasatinib/nilotinib

Various toxicities: case report
Case report
  • 11 Downloads

Reference

  1. Elnair R, et al. Finding the right BCR-ABL1 tyrosine kinase inhibitor: A case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib. BMC Cancer 18: 1097, No. 1, 12 Nov 2018. Available from: URL: http://doi.org/10.1186/s12885-018-5004-3 - USA

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations